2004•PubMedRequires access

[BCG vaccination: where are we now?].

Taner Yavuz, Peri Arbak, Cihadiye Elif Öztürk, Kenan Kocabay

Open publisher page 2 citations

Abstract

The bacillus Calmette-Guerin (BCG) vaccine is administered and recommended for the prevention and control of tuberculosis in developing countries with high-risk settings. A new general BCG vaccination programme against tuberculosis has been introduced since 1997 in Turkey. The aim of this study was to evaluate the BCG vaccination status in Düzce and to analyze contributing factors for the vaccination programme. BCG screening were performed in 1100 8th class students from nine primary schools of Düzce city centre and seven counties. BCG scar presence was taken as authoritative for vaccination status. BCG vaccination ratio was 0.94. Of 1100 students, 1030 had BCG scars; 478 had single scar, 536 had two scars and 16 had three scars. The significant negative correlation was observed between the BCG administration ratio and the number of children under age of 15 per health personnel (r= -0.771, p= 0.025). Furthermore, based on some published studies marked regional variation of BCG vaccination status in Turkey was also discussed in this article.

About this research paper

What this paper is about

The bacillus Calmette-Guerin (BCG) vaccine is administered and recommended for the prevention and control of tuberculosis in developing countries with high-risk settings. A new general BCG vaccination programme against tuberculosis has been introduced since 1997 in Turkey. The aim of this study was to evaluate the BCG vaccination status in Düzce and to analyze contributing factors for the vaccination programme. BCG screening were performed in 1100 8th class students from nine primary schools of Düzce city centre and seven counties. BCG scar presence was taken as authoritative for vaccination status. BCG vaccination ratio was 0.94. Of 1100 students, 1030 had BCG scars; 478 had single scar, 536 had two scars and 16 had three scars. The significant negative correlation was observed between the BCG administration ratio and the number of children under age of 15 per health personnel (r= -0.771, p= 0.025). Furthermore, based on some published studies marked regional variation of BCG vaccination status in Turkey was also discussed in this article.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The bacillus Calmette-Guerin (BCG) vaccine is administered and recommended for the prevention and control of tuberculosis in developing countries with high-risk settings. A new general BCG vaccination programme against tuberculosis has been introduced since 1997 in Turkey. The aim of this study was to evaluate the BCG vaccination status in Düzce and to analyze contributing factors for the vaccination programme. BCG screening were performed in 1100 8th class students from nine primary schools of Düzce city centre and seven counties. BCG scar presence was taken as authoritative for vaccination status. BCG vaccination ratio was 0.94. Of 1100 students, 1030 had BCG scars; 478 had single scar, 536 had two scars and 16 had three scars. The significant negative correlation was observed between the BCG administration ratio and the number of children under age of 15 per health personnel (r= -0.771, p= 0.025). Furthermore, based on some published studies marked regional variation of BCG vaccination status in Turkey was also discussed in this article.

Key concepts: Vaccination, Medicine, BCG vaccine, Scars, Tuberculosis, Environmental health, Immunology, Pediatrics

Back to paper searchBrowse research topicsOriginal source
[BCG vaccination: where are we now?]. — Research Paper | ScholarLens